Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation

Cited in blog · Lancet Diabetes & Endocrinology. · 2025

Prado CM (2025). Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation. *Lancet Diabetes & Endocrinology*.

Authors

Prado CM

Research lens

Prado CM (2025). Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation. *Lancet Diabetes & Endocrinology*.

  • blog
  • glp1-protein-demand-circana-2026-09-04